Literature DB >> 6546576

Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies.

P Beck-Peccoz, P B Romelli, M G Cattaneo, G Faglia, E L White, J W Barlow, J R Stockigt.   

Abstract

Circulating iodothyronine-binding autoantibodies interfere with total T4 and T3 RIAs, giving falsely high or falsely low values depending on the assay separation method used. Direct serum free T4 (FT4) measurement should compensate for such abnormal binding if the method is free of artefact. We assessed 5 different FT4 methods in 12 patients with immunoglobulin binding of iodothyronines, with limited assessment of a sixth method in 2 subjects. Thyroid status was assessed clinically and by measurement of TSH and its response to TRH. T4 methods which use analog tracers, i.e. Amerlex, and Clinical Assays One-step FT4, gave spuriously high values in almost all hypothyroid and some euthyroid patients, due to immunoglobulin binding of the tracers used in these techniques. The kinetic indirect method (Corning Immunophase FT4) gave inappropriately high values in 4 of 6 hypothyroid patients. FT4 by equilibrium dialysis or by adsorption chromatography and RIA, accurately assessed thyroid status. These findings suggest that FT4 methods are valid in patients with circulating iodothyronine-binding immunoglobulins only if the free hormone fraction is physically separated from serum binding proteins before the assay procedure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546576     DOI: 10.1210/jcem-58-4-736

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays.

Authors:  O P Soldin; L Hilakivi-Clarke; E Weiderpass; S J Soldin
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

Review 2.  Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2006-02       Impact factor: 3.681

3.  Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide.

Authors:  Offie P Soldin; Danielle Soldin; Marisol Sastoque
Journal:  Ther Drug Monit       Date:  2007-10       Impact factor: 3.681

Review 4.  Circulating thyroid hormone autoantibodies.

Authors:  S Benvenga; F Trimarchi; J Robbins
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

5.  Influence of endogenous T3-autoantibodies on thyroid hormone measurements in a woman with transient postpartum thyroiditis.

Authors:  R Jansson; R Forberg
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

6.  Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels.

Authors:  B Cavaco; V Leite; M M Loureiro; M F Ferreira; M C Pereira; M A Santos; L G Sobrinho
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

7.  Plasma thyrotropin, thyroxine, triiodothyronine, free thyroxine, free triiodothyronine, and cortisol levels in blind prepubertal boys.

Authors:  A Bellastella; T Criscuolo; A A Sinisi; S Iorio; A Mazzuca; F Parlato; L Perrone; M Faggiano
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

8.  Differences between measurements of T4 and T3 in pregnant and nonpregnant women using isotope dilution tandem mass spectrometry and immunoassays: are there clinical implications?

Authors:  Offie P Soldin; Rochelle E Tractenberg; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2004-09       Impact factor: 3.786

9.  Isotope dilution tandem mass spectrometric method for T4/T3.

Authors:  Nadia Soukhova; Offie P Soldin; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2004-05       Impact factor: 3.786

10.  Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone.

Authors:  A Loviselli; L Bartalena; S Balzano; F Aghini-Lombardi; V Sica; R Pilosu; L Petrini; G Giannessi; L Buratti; E Martino
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.